Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Prostate. 2020 Jun 7;80(11):895–905. doi: 10.1002/pros.24023

TABLE 1.

Characteristics of 247 controls in the placebo arm of PCPT by the prevalence and extent of inflammation in prostate biopsy cores

Prostate biopsy cores with inflammation
Overall None Anya Some All
N 247 55 192 127 65
Mean age, y 64 63 65 64 65
White, % 83.4 85.5 82.8 82.7 83.1
Smoking status, %
 Current 5.3 5.4 5.2 4.7 6.2
 Former 62.4 65.5 61.5 60.6 63.1
 Never 32.4 29.1 33.3 34.7 30.8
Attained education, %
 High school or lower 18.6 10.9 20.8 20.5 21.5
 Some college, college graduate 46.2 61.8 41.7 41.7 41.5
 Graduate school 35.2 27.3 37.5 37.8 36.9
Mean BMI, kg/m2 27.5 27.8 27.4 27.3 27.7
Mean waist circumference, cm 102 102 102 102 103
Activity level, %
 Sedentary or light 55.9 49.9 57.8 58.3 56.9
 Moderate or active 44.1 50.9 42.2 41.7 43.1
History of diabetes, % 8.9 12.7 7.8 8.7 6.2
Mean cholesterol concentration, mg/dL 205 206 204 204 205
Mean alcohol intake, g/d 7.7 9.1 7.3 7.1 7.5
Mean red meat intake, g/d 0.65 0.58 0.65 0.66 0.64
Family history of prostate cancer, % 17.8 16.4 18.2 17.3 20.0
Mean baseline PSA concentration, ng/mL 1.17 0.88 1.26 1.21 1.35
Mean biopsy PSA concentration, ng/mL 1.97 1.24 2.17 1.53 3.42
a

Some or all cores inflamed.